Literature DB >> 29767957

Magnetic Manipulation of Reversible Nanocaging Controls In Vivo Adhesion and Polarization of Macrophages.

Heemin Kang1, Hee Joon Jung2, Sung Kyu Kim2, Dexter Siu Hong Wong1, Sien Lin3, Gang Li4, Vinayak P Dravid2, Liming Bian1,3,5,6,7.   

Abstract

Macrophages are key immune cells that perform various physiological functions, such as the maintenance of homeostasis, host defense, disease progression, and tissue regeneration. Macrophages adopt distinctly polarized phenotypes, such as pro-inflammatory M1 phenotype or anti-inflammatory (pro-healing) M2 phenotype, to execute disparate functions. The remotely controlled reversible uncaging of bioactive ligands, such as Arg-Gly-Asp (RGD) peptide, is an appealing approach for temporally regulating the adhesion and resultant polarization of macrophages on implants in vivo. Here, we utilize physical and reversible uncaging of RGD by a magnetic field that allows facile tissue penetration. We first conjugated a RGD-bearing gold nanoparticle (GNP) to the substrate and then a magnetic nanocage (MNC) to the GNP via a flexible linker to form the heterodimeric nanostructure. We magnetically manipulated nanoscale displacement of MNC and thus its proximity to the GNP to reversibly uncage and cage RGD. The uncaging of RGD temporally promoted the adhesion and subsequent M2 polarization of macrophages while inhibiting their M1 polarization both in vitro and in vivo. The RGD uncaging-mediated adhesion and M2 polarization of macrophages involved rho-associated protein kinase signaling. This study demonstrates physical and reversible uncaging of RGD to regulate the adhesion and polarization of host macrophages in vivo. This approach of magnetically regulating the heterodimer conformation for physical and reversible uncaging of RGD offers the promising potential to manipulate inflammatory or tissue-regenerative immune responses to the implants in vivo.

Keywords:  heterodimer; macrophage adhesion; macrophage polarization; magnetic nanocaging; remote manipulation; reversible caging

Mesh:

Substances:

Year:  2018        PMID: 29767957     DOI: 10.1021/acsnano.8b02226

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  14 in total

1.  Immunomodulation and delivery of macrophages using nano-smooth drug-loaded magnetic microrobots for dual targeting cancer therapy.

Authors:  Xiaoxia Song; Wei Fu; U Kei Cheang
Journal:  iScience       Date:  2022-06-02

Review 2.  Harnessing the Therapeutic Potential of Extracellular Vesicles for Biomedical Applications Using Multifunctional Magnetic Nanomaterials.

Authors:  Letao Yang; Kapil D Patel; Christopher Rathnam; Ramar Thangam; Yannan Hou; Heemin Kang; Ki-Bum Lee
Journal:  Small       Date:  2022-02-08       Impact factor: 15.153

Review 3.  Immunomodulatory Nanosystems.

Authors:  Xiangru Feng; Weiguo Xu; Zhongmin Li; Wantong Song; Jianxun Ding; Xuesi Chen
Journal:  Adv Sci (Weinh)       Date:  2019-06-21       Impact factor: 16.806

Review 4.  Tailoring Materials for Modulation of Macrophage Fate.

Authors:  Jinhua Li; Xinquan Jiang; Hongjun Li; Michael Gelinsky; Zhen Gu
Journal:  Adv Mater       Date:  2021-02-09       Impact factor: 32.086

5.  Phenotypic switch of human and mouse macrophages and resultant effects on apoptosis resistance in hepatocytes.

Authors:  Li Bai; Yu Chen; Sujun Zheng; Feng Ren; Ming Kong; Shuang Liu; Yuanping Han; Zhongping Duan
Journal:  Innate Immun       Date:  2019-02-25       Impact factor: 2.680

6.  Dandelion-Like Tailorable Nanoparticles for Tumor Microenvironment Modulation.

Authors:  Qin Guo; Xi He; Chao Li; Yongqing He; Yiying Peng; Yu Zhang; Yifei Lu; Xinli Chen; Yujie Zhang; Qinjun Chen; Tao Sun; Chen Jiang
Journal:  Adv Sci (Weinh)       Date:  2019-09-12       Impact factor: 16.806

Review 7.  Functionalized Nanomaterials as Tailored Theranostic Agents in Brain Imaging.

Authors:  Ramar Thangam; Ramasamy Paulmurugan; Heemin Kang
Journal:  Nanomaterials (Basel)       Date:  2021-12-22       Impact factor: 5.076

Review 8.  Harnessing Tissue-derived Extracellular Vesicles for Osteoarthritis Theranostics.

Authors:  Bohan Yin; Junguo Ni; Claire E Witherel; Mo Yang; Jason A Burdick; Chunyi Wen; Siu Hong Dexter Wong
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

9.  In vivo liposomal delivery of PPARα/γ dual agonist tesaglitazar in a model of obesity enriches macrophage targeting and limits liver and kidney drug effects.

Authors:  Victoria Osinski; Dustin K Bauknight; Siva Sai Krishna Dasa; Matthew J Harms; Tobias Kroon; Melissa A Marshall; James C Garmey; Anh T Nguyen; Julia Hartman; Aditi Upadhye; Prasad Srikakulapu; Andrea Zhou; Gavin O'Mahony; Alexander L Klibanov; Kimberly A Kelly; Jeremie Boucher; Coleen A McNamara
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

Review 10.  Immunologically Inert Nanostructures as Selective Therapeutic Tools in Inflammatory Diseases.

Authors:  Laura Talamini; Eiji Matsuura; Luisa De Cola; Sylviane Muller
Journal:  Cells       Date:  2021-03-23       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.